Previous Speakers

Abraham Heifets

Co-Founder & CEO

Atomwise

Petrina Kamya

Global Head of AI Platforms, VP Insilico Medicine President

Insilico Medicine Canada Inc.

Elena Diaz Cecilia

Senior Director, External Innovation

Janssen R&D

Daniel Jamieson

CEO

Biorelate

Byungchan Kim

Executive Director in Drug Discovery

XTALPI

Dane Corneil

AI Lead for Target-ID

Benevolentai

Claire Zhao

Associate Director of AI/ML & Quantitative and Digital Sciences

PFIZER

Nick Nystrom

Chief Technology Officer

Peptilogics

Aaron Mackey

VP Head of AI and ML

Sonata

Chris Tame

VP Head of Drug Discovery

CELERIS THERAPEUTICS

Martin Gershon

Managing Partner & CIO

Endeavor Life Sciences Venture Funds

Dr. Martin Gershon is the Managing Partner and CIO of Endeavor Life Sciences Venture Funds ($1B AUM) and Venture Studio ($570M AUM). He has been featured on CNBC and in numerous conferences and publications as one of the leading healthcare investors, strategists, futurists and entrepreneurs. Over the past 23 years he raised over $1B, personally founded/exited 6 startups, lead Endeavor Funds to 69 investments, and has served as Senior Strategic Healthcare Advisor for Fortune 500 Companies including McKinsey, Goldman Sachs, Bain Capital, Fidelity, TPG, BlackRock, Tiger Global, GlaxoSmithKline, Bristol-Myers Squibb, Pfizer, Novartis, Rockefeller Foundation, WHO, and the Bill and Melinda Gates Foundation.

Dr. Gershon has been honored by Standard and Poor’s as a designated top 100 “Healthcare Industry Leader” and has developed Endeavor into a thriving ecosystem of partnerships with BioPharma, Medtech, Digital Health, and Big Tech companies, world class CEO entrepreneurs, start-up accelerators, and prominent Ivy League universities, medical centers, and business schools like Harvard, Columbia, MIT, NYU, McGill and Johns Hopkins.

Dr. Gershon is committed to helping emerging CEO/Founder Entrepreneurs and serves as a Lead Mentor for Techstars and as a member of the Techstars Start-Up Selection Committee, Executive-in-Residence and Advisor for Matter Health, Mentor for NYU Berkley Center for Entrepreneurship, Selection Committee Advisor for Ben Franklin Technology Partners, Investor for PlugNPlay Tech Center, Advisory Board Member McGill Innovation Fund, and Investor and Advisor for MassChallenge.

Dr. Gershon is a former Aspen Institute Business of Health Chair and Senior Fellow, Memorial Sloan-Kettering Cancer Center Mayday Fellow, Harvard and Columbia trained neuroscientist, oncologist, immunologist, FDA attorney, Lecturer and Professor at Harvard, MIT, Johns Hopkins, Oxford, Columbia, Chief of Innovation and Investment at McGill, and a contributing author of healthcare entrepreneurship and finance at Fast Company.

Liz Schwarzbach

Chief Business Officer

BigHat Biosciences

Simon Beaulah

SVP Precision Drug Repositioning

PRECISIONLIFE

Gary An

Professor of Surgery and Board Member Complexity in Acute Illness

University of Vermont

Max Liu

Senior Software Engineer - Early Science

AstraZeneca

Hunter Elliot

Principal Machine Learning Scientist

BigHat Biosciences

Sourav Bandyopadhyay

Chief Technology Officer

Rezo Therapeutics

Lu Zhang

Founder & Managing Partner

Fusion Fund